000 04361nam a22003975i 4500
999 _c392311
_d392311
001 392311
003 ES-MaUEC
005 20230930125347.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 110711s2011 xxu| fo |||| 0|eng d
020 _a9781617791888
024 7 _a10.1007/978-1-61779-188-8
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRM666 .N87
_b2011 EB
245 0 0 _aTherapeutic Oligonucleotides :
_bMethods and Protocols
_cedited by John Goodchild
250 _a1st edition 2011
264 1 _aTotowa, NJ
_bHumana Press
_c2011
300 _a1 recurso en línea (XI, 340 páginas)
_b70 ilustraciones
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aMethods in Molecular Biology
_x1940-6029
_v764
505 0 _aTherapeutic Oligonucleotides -- Dinucleotides Containing 3¢-S-Phosphorothiolate Linkages -- 2'-O,4'-C-Methyleneoxymethylene Bridged Nucleic Acids (2',4'-BNACOC) -- A Non-covalent Peptide-based Strategy for Ex-vivo and In vivo Oligonucleotide Delivery -- Cell Penetrating Peptides-based Strategies for the Delivery of Splice Redirecting Antisense Oligonucleotides -- A Nanoparticle for Tumor Targeted Delivery of Oligomers -- Light-directed Delivery of Nucleic Acids -- Antibody Targeted siRNA Delivery -- Aptamer-Drug Conjugation for Targeted Tumor Cell Therapy -- Five-step Process for Screening Antisense Compounds for Efficacy: Gene Target IL-12Rb2 -- Diverse Small Non-coding RNAs in RNA Interference Pathways -- Quantification of siRNAs In vitro and In vivo -- Optimization of Transfection Conditions and Analysis of siRNA Potency Using Real-time PCR -- siRNA Knockdown of Gene Expression in Endothelial Cells -- Using RNA Interference in Schistosoma mansoni -- Performing the Labeled microRNA Pull-down (LAMP) Assay System: An Experimental Approach for High-throughput Identification of microRNA-target mRNAs -- Synthesis, Purification, and Characterization of Oligoribonucleotides that Act as Agonists of TLR7 and/or TLR8 -- Synthesis, Purification, and Characterization of Immune-Modulatory Oligodeoxynucleotides that Act as Agonists of Toll-like Receptor 9 -- Surface Plasmon Resonance Investigation of RNA Aptamer-RNA Ligand Interactions -- Practical Considerations for Analyzing Antigene RNAs (agRNAs): RNA Immunoprecipitation of Argonaute Protein -- Inhibition of Human Papillomavirus Expression Using DNAzymes.
520 _aThe field of oligonucleotide therapeutics research is ripe with the prospect of new discoveries. In Therapeutic Oligonucleotides: Methods and Protocols, a selection of established and emerging methods for the application of oligonucleotides as therapeutics are presented, all providing the tools needed to inspire great changes in the field. Divided into twenty-one chapters, this detailed volume meticulously describes vital protocols for optimizing and improving cell uptake, such as photochemical internalization, modified cell penetrating peptides, antibody conjugates, and nanoparticles. Other chapters address quantitation of RNA therapeutics in cells, assaying gene knockdown, selecting the best target site and synthesis of various modified oligonucleotides. Written in the successful Methods in Molecular Biology™ series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and notes on troubleshooting and avoiding known pitfalls.   Authoritative and easily accessible, Therapeutic Oligonucleotides: Methods and Protocols serves as a timely resource for both professionals and novices pursuing research in this exciting and pioneering field.
988 _aSpringer_Protocols_2011
650 7 _2embne
_9140525
_aÁcidos nucleicos
_vManuales de laboratorio
776 0 8 _iPrinted edition:
_z9781617791871
776 0 8 _iPrinted edition:
_z9781617791895
776 0 8 _iPrinted edition:
_z9781493958221
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-61779-188-8
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b09/2023
_dz
_eu
_zSI